Abstract:Cellular senescence is an irreversible cell arrest process, which is determined by a variety of complicated mechanisms, including telomere attrition, mitochondrial dysfunction, metabolic disorders, loss of protein homeostasis, epigenetic changes, etc. Cellular senescence is causally related to the occurrence and development of age-related disease. The elderly is liable to suffer from disorders such as neurodegenerative diseases, cancer, and diabetes. Therefore, it is increasingly imperative to explore specific countermeasures for the treatment of age-related diseases. Numerous studies on humans and mice emphasize the significance of metabolic imbalance caused by short telomeres and mitochondrial damages in the onset of age-related diseases. Although the experimental data are relatively independent, more and more evidences have shown that there is mutual crosstalk between telomeres and mitochondrial metabolism in the process of cellular senescence. This review systematically discusses the relationship between telomere length, mitochondrial metabolic disorder, as well as their underlying mechanisms for cellular senescence and age-related diseases. Future studies on telomere and mitochondrial metabolism may shed light on potential therapeutic strategies for age-related diseases.Graphical The characteristics of cellular senescence mainly include mitochondrial dysfunction and telomere attrition. Mitochondrial dysfunction will cause mitochondrial metabolic disorders, including decreased ATP production, increased ROS production, as well as enhanced cellular apoptosis. While oxidative stress reaction to produce ROS, leads to DNA damage, and eventually influences telomere length. Under the stimulation of oxidative stress, telomerase catalytic subunit TERT mainly plays an inhibitory role on oxidative stress, reduces the production of ROS and protects telomere function. Concurrently, mitochondrial dysfunction and telomere attrition eventually induce a range of age-related diseases, such as T2DM, osteoporosis, AD, etc. :increase; :reduce;⟝:inhibition.

NAD-Linked Metabolism and Intervention in Short Telomere Syndromes and Murine Models of Telomere Dysfunction

Re-equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction

Boosting NAD ameliorates hematopoietic impairment linked to short telomeres in vivo

Telomere function and regulation from mouse models to human ageing and disease

Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule

Lifelong Docosahexaenoic Acid Intervention Ameliorates Aging in the Telomere-Dna-mitochondria Axis in Telomerase-Deficient Mice

NAD metabolism: Role in senescence regulation and aging

Telomeres and Mitochondrial Metabolism: Implications for Cellular Senescence and Age-related Diseases

NAD+ Repletion Improves Mitochondrial and Stem Cell Function and Enhances Life Span in Mice

The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside

The Impacts of Short-Term NMN Supplementation on Serum Metabolism, Fecal Microbiota, and Telomere Length in Pre-Aging Phase

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases

Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease

Telomeric Injury by KML001 in Human T Cells Induces Mitochondrial Dysfunction Through the P53-Pgc-1α Pathway.

Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan

Targeting NAD+ Metabolism: Preclinical Insights into Potential Cancer Therapy Strategies

Potential Roles of Telomeres and Telomerase in Neurodegenerative Diseases.

Unlocking Mitochondrial Dysfunction-Associated Senescence (MiDAS) with NAD -- a Boolean Model of Mitochondrial Dynamics and Cell Cycle Control

Loss of Telomere Protection: Consequences and Opportunities

Abstract 44: Telomere and Mitochondrial Dysfunction in Duchenne Muscular Dystrophy